2 results match your criteria: "Cedars-Sinai Medical Center and Geffen School of Medicine UCLA[Affiliation]"
Guidelines for the correct use of the nomenclature of biochemical indices of bone status: a position statement of the Joint IOF Working Group and IFCC Committee on Bone Metabolism.
Clin Chem Lab Med
November 2024
Department of Clinical Chemistry, CIRM, University of Liège, CHU de Liège, Belgium.
Article Synopsis
- - The guidelines update the International Osteoporosis Foundation's (IOF) 20-year-old position paper on bone markers, reflecting advancements in bone biology and disorders.
- - The authors introduce a new classification called Bone Status Indices (BSI) to replace outdated terms like bone turnover markers and metabolic markers for better clarity.
- - The proposal includes standardized nomenclature, abbreviations, and measurement units for these indices to ensure consistency in the study and treatment of bone health.
Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review.
Osteoporos Int
August 2024
Cedars-Sinai Medical Center and Geffen School of Medicine UCLA, Los Angeles, CA, USA.
Article Synopsis
- - Antiresorptive medications for osteoporosis do not negatively impact the healing of fractures in humans, and teriparatide may actually help shorten healing time.
- - The fracture healing process involves multiple steps, with imaging and clinical evaluations being crucial for assessing progress, and there is no need to stop osteoporosis treatment when a fracture occurs.
- - Despite animal studies showing some benefits of romosozumab on healing, clinical evidence in humans does not support these findings, indicating that its effectiveness may be limited.